Volgen
Jesse Salk
Jesse Salk
University of Washington
Geverifieerd e-mailadres voor u.washington.edu
Titel
Geciteerd door
Geciteerd door
Jaar
Detection of ultra-rare mutations by next-generation sequencing
MW Schmitt, SR Kennedy, JJ Salk, EJ Fox, JB Hiatt, LA Loeb
Proceedings of the National Academy of Sciences 109 (36), 14508-14513, 2012
12322012
Detecting ultralow-frequency mutations by Duplex Sequencing
SR Kennedy, MW Schmitt, EJ Fox, BF Kohrn, JJ Salk, EH Ahn, MJ Prindle, ...
Nature protocols 9 (11), 2586-2606, 2014
6112014
Enhancing the accuracy of next-generation sequencing for detecting rare and subclonal mutations
JJ Salk, MW Schmitt, LA Loeb
Nature Reviews Genetics 19 (5), 269-285, 2018
5422018
Ultra-sensitive sequencing reveals an age-related increase in somatic mitochondrial mutations that are inconsistent with oxidative damage
SR Kennedy, JJ Salk, MW Schmitt, LA Loeb
PLoS genetics 9 (9), e1003794, 2013
4422013
Mutational heterogeneity in human cancers: origin and consequences
JJ Salk, EJ Fox, LA Loeb
Annual Review of Pathology: Mechanisms of Disease 5 (1), 51-75, 2010
3792010
The influence of subclonal resistance mutations on targeted cancer therapy
MW Schmitt, LA Loeb, JJ Salk
Nature reviews Clinical oncology 13 (6), 335-347, 2016
2502016
Methods of lowering the error rate of massively parallel DNA sequencing using duplex consensus sequencing
M Schmitt, J Salk, LA Loeb
US Patent 9,752,188, 2017
1912017
Optimization of DNA polymerase mutation rates during bacterial evolution
E Loh, JJ Salk, LA Loeb
Proceedings of the National Academy of Sciences 107 (3), 1154-1159, 2010
1022010
Decreased mitochondrial DNA mutagenesis in human colorectal cancer
NG Ericson, M Kulawiec, M Vermulst, K Sheahan, J O'Sullivan, JJ Salk, ...
PLOS genetics 8 (6), e1002689, 2012
992012
Ultra-sensitive TP53 sequencing for cancer detection reveals progressive clonal selection in normal tissue over a century of human lifespan
JJ Salk, K Loubet-Senear, E Maritschnegg, CC Valentine, LN Williams, ...
Cell Reports 28 (1), 132-144. e3, 2019
952019
Methods of lowering the error rate of massively parallel DNA sequencing using duplex consensus sequencing
J Salk, LA Loeb, M Schmitt
US Patent 10,385,393, 2019
932019
Next‐generation genotoxicology: using modern sequencing technologies to assess somatic mutagenesis and cancer risk
JJ Salk, SR Kennedy
Environmental and Molecular Mutagenesis 61 (1), 135-151, 2020
902020
Direct quantification of in vivo mutagenesis and carcinogenesis using duplex sequencing
CC Valentine III, RR Young, MR Fielden, R Kulkarni, LN Williams, T Li, ...
Proceedings of the National Academy of Sciences 117 (52), 33414-33425, 2020
892020
Methods of lowering the error rate of massively parallel DNA sequencing using duplex consensus sequencing
J Salk, LA Loeb, M Schmitt
US Patent 10,689,699, 2020
892020
Methods of lowering the error rate of massively parallel DNA sequencing using duplex consensus sequencing
J Salk, LA Loeb, M Schmitt
US Patent 10,287,631, 2019
872019
Methods of lowering the error rate of massively parallel DNA sequencing using duplex consensus sequencing
J Salk, LA Loeb, M Schmitt
US Patent 10,752,951, 2020
862020
Methods of lowering the error rate of massively parallel DNA sequencing using duplex consensus sequencing
J Salk, LA Loeb, M Schmitt
US Patent 10,370,713, 2019
832019
Cancer genome sequencing—an interim analysis
EJ Fox, JJ Salk, LA Loeb
Cancer research 69 (12), 4948-4950, 2009
802009
Methods of lowering the error rate of massively parallel DNA sequencing using duplex consensus sequencing
J Salk, LA Loeb, M Schmitt
US Patent 10,604,804, 2020
792020
Clonal expansions in ulcerative colitis identify patients with neoplasia
JJ Salk, SJ Salipante, RA Risques, DA Crispin, L Li, MP Bronner, ...
Proceedings of the National Academy of Sciences 106 (49), 20871-20876, 2009
712009
Het systeem kan de bewerking nu niet uitvoeren. Probeer het later opnieuw.
Artikelen 1–20